Page 21 - All Act News Today

Stuart Butler and Nehath Sheriff explore how communities are addressing the connection between mental health and poverty, focusing on three public health issues: homelessness, food insecurity, and hygiene poverty.

Associated Students Campus Wide Senator Liane Barkhordar heads the launch of the Period Pilot Project in order to combat period poverty and increase accessibility of period products on campus.   Liane Barkhordar remembers looking through the recesses of her backpack for a pad and coming up empty. Barkhordar headed to a campus bathroom, where she...

A judge in Montana refused to dismiss a lawsuit that alleges the state’s unique constitutional requirement to teach students about Native American history and culture has not been upheld.

Bluewater Health is ramping up diversity, equity and inclusion training as part of its newest quality improvement plan.

Associated Students Campus Wide Senator Liane Barkhordar heads the launch of the Period Pilot Project in order to combat period poverty and increase accessibility of period products on campus.   Liane Barkhordar remembers looking through the recesses of her backpack for a pad and coming up empty. Barkhordar headed to a campus bathroom, where she...

EDUCATION NOTEBOOK:  Beauprez Looks to the States to Move Beyond No Child Left Behind July 27, 2006 It's been said that everything old becomes new again. This is proving true in the federal education reform debate. A conservative congressman has introduced new legislation based on an old idea: local control over education.  

A judge refused to dismiss a lawsuit claiming that Montana has not upheld the state constitution’s Native American education requirements.

A judge in Montana refused to dismiss a lawsuit Tuesday that alleges the states unique constitutional requirement to teach students about Native American history and culture has not been upheld.

Period poverty is widespread in the US, and Covid worsened the crisis. Yet it remains ‘shrouded in stigma and shame’

Insulin is finally seeing enormous price cuts. Could EpiPens be next?